1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement
At baseline, FAPI and FDG are performed to evaluate the activity of takayasu arteritis with pulmonary artery involvement. FAPI is also used to predict the treatment efficacy and prognosis of takayasu arteritis with pulmonary artery involvement.
Study Type
OBSERVATIONAL
Enrollment
200
Percutaneous transluminal pulmonary angioplasty
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
RECRUITINGall cause death
all cause death
Time frame: 2014/1/1-2042/12/31
mean pulmonary arterial pressure change
change of mean pulmonary arterial pressure after treatment
Time frame: 2014/1/1-2042/12/31
pulmonary vascular resistance change
chagne of pulmonary vascular resistance after treatment
Time frame: 2014/1/1-2042/12/31
6MWD change
change of six minute walk distance after treatment
Time frame: 2014/1/1-2042/12/31
peak VO2 change
change of peak oxygen consumption after treatment
Time frame: 2014/1/1-2042/12/31
NT-proBNP change
change of NT-proBNP after treatment
Time frame: 2014/1/1-2042/12/31
RV/LV change
change of right ventricular end-diastolic diameter versus laboratory left ventricular end-diastolic diameterafter treatment
Time frame: 2014/1/1-2042/12/31
CI change
change of cardiac index after treatment
Time frame: 2014/1/1-2042/12/31
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.